Welcome to the 3rd World Conference on Targeting Liver Diseases
After the success of the two previous editions, we are pleased to announce to you the organization of the 3rd World Conference on Targeting Liver Diseases: Sciences, Clinical Innovations & Biotechnology to be held in Lisbon, Portugal on November 2023.
Targeting Liver Diseases 2023 is not just another liver meeting to update on liver progress. However, we are creating a kind of mind-storming forum to create new therapeutic approaches that are targeting the liver.
Not only liver research and topics are proposed, but also other important research easing up a liver benefit. It could be research tools in other fields that implicate liver research or important nonliver pathways that are the potential to be helpful in future liver research. During Targeting Liver 2016, we will initiate new channels and fields such as Microbiota, Stem Cells, and Mitochondria and wave them to liver homeostasis and pathologies.
Therefore, Targeting Liver Diseases 2023 is including also non liver topics to be exposed for the liver researchers to enrich their knowledge. The same with the clinical and basic science combination that are coming to feed each side more proximity and lead to more focused research based on real needs.
Targeting Liver Diseases 2023 will be divided into two days:
Day One: Targeting Liver Diseases 2023 Recent Advances & Perspectives
- Liver Diseases & Primary Sclerosing Cholangitis
- Liver Diseases & Cancer
- Liver Diseases, Oxidative Stress, Mitochondria & Microbiota
- Liver Diseases & Endotoxins
- Liver Transplantation
- Liver Diseases & Fibrosis
- Fatty Liver Diseases
- Liver Diseases & Viral Infection
Day Two: Targeting Liver Diseases 2023: The Innovations
Targeting Liver 2023 : new targets and therapies in liver diseases
Targeting Liver 2023 will provide a unique and rare opportunity for interactions between industry and liver disease experts. Seeking to help identify unmet needs in hepatology, these 2 days will look toward the future to determine how to address the long-term challenges that hepatologists are likely to face in the coming years.
We look forward to meeting you in sunny Lisbon next July.
Prof. Marvin Edeas - Prof. Rifaat Safadi
Chairmen of the Scientific Committee
